• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of aspirin on 14C-pirprofen disposition in rats.

作者信息

Thompson T A, Borman C H, Goodblatt R S, Roth W J

出版信息

J Pharm Sci. 1979 Aug;68(8):996-8. doi: 10.1002/jps.2600680820.

DOI:10.1002/jps.2600680820
PMID:480180
Abstract

The effects of aspirin on 14C-pirprofen disposition in the rat were studied. An oral 60-mg/kg dose of aspirin significantly reduced plasma radioactivity during the 1--8-hr interval after an intravenous 5-mg/kg injection of 14C-pirprofen. The aspirin-treated group had only 69% as much area under the radioactivity curve as the control group. The radioactive material in plasma consisted almost entirely of 14C-pirprofen, as shown by GLC. The plasma clearance of 14C-pirprofen was 7.4 ml/hr for the aspirin-treated group and 5.1 ml/hr for the control group, while the volumes of distribution were 0.32 and 0.20 liter/kg, respectively. The apparent elimination half-life was unchanged at 5.9 hr. 14C-Pirprofen was approximately 98.6% bound to plasma proteins, and the binding decreased to an average of 97.2% in the presence of salicylate. Binding to blood cellular constituents was insignificant. Rats give 14C-pirprofen by intravenous injection without aspirin secreted 36.0--42.8% of the dose radioactivity into bile during 4 hr while a comparable group given 60 mg of aspirin/kg secreted 46.4--70.8%. TLC and GLC demonstrated that the radioactivity in rat bile was 80--90% conjugated 14C-pirprofen. The increased radioactive material secretion into bile was compensated in the intact rat by reabsorption, since the total radioactive material excreted in urine was not changed by aspirin administration.

摘要

相似文献

1
Effects of aspirin on 14C-pirprofen disposition in rats.
J Pharm Sci. 1979 Aug;68(8):996-8. doi: 10.1002/jps.2600680820.
2
Disposition of pirprofen, a new anti-inflammatory drug.新型抗炎药吡洛芬的处置
Clin Pharmacol Ther. 1977 Jun;21(6):721-30. doi: 10.1002/cpt1977216721.
3
Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.新型认知增强剂NS-105的药代动力学。首次通讯:单次给予14C-NS-105后在大鼠、犬和猴体内的吸收、代谢及排泄情况
Arzneimittelforschung. 1999 Nov;49(11):881-90. doi: 10.1055/s-0031-1300521.
4
Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.新型降胆固醇化合物S-8921在大鼠和犬体内的处置与代谢
Arzneimittelforschung. 1998 Oct;48(10):995-1006.
5
[Absorption, distribution, metabolism and excretion of netilmicin in rats (III). Metabolic fate of 14C-netilmicin after intramuscular administration (author's transl)].
Jpn J Antibiot. 1982 Apr;35(4):967-78.
6
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
7
Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.苯乙胺类α1A -肾上腺素能受体激动剂NS - 49的药代动力学。首次通讯:单次给予14C - NS - 49后在大鼠体内的吸收与排泄
Arzneimittelforschung. 1999 May;49(5):434-40. doi: 10.1055/s-0031-1300439.
8
Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.低剂量14C-双酚A在雄性大鼠体内的处置及其以双酚A葡萄糖醛酸苷形式的主要胆汁排泄
Toxicol Sci. 2003 May;73(1):17-25. doi: 10.1093/toxsci/kfg040. Epub 2003 Apr 15.
9
Disposition and metabolism of [14C]-haloperidol in rats.大鼠体内[14C] - 氟哌啶醇的处置与代谢
Arzneimittelforschung. 1986 Mar;36(3):443-52.
10
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.新型类视黄醇4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸的代谢与处置研究。第四次通讯:在各种动物和人类中的吸收、代谢、排泄及血浆蛋白结合情况
Arzneimittelforschung. 1997 Mar;47(3):259-69.

引用本文的文献

1
Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.吡洛芬。对其药效学和药代动力学特性以及治疗效果的综述。
Drugs. 1986 Dec;32(6):509-37. doi: 10.2165/00003495-198632060-00003.